ELITE PHARMACEUTICALS INC /NV/ 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Feb 27, 2017
Insider Transaction Report
Form 4
Hakim Nasrat A
DirectorPresident & CEO
Transactions
- Award
Common Stock
2017-02-23$0.23/sh+2,216,992$499,932→ 24,143,785 total
Holdings
- 2,700,000(indirect: By IRA)
Common Stock
- 142,971,097(indirect: see footnote)
Common Stock
Footnotes (1)
- [F1]The securities are held by Mikah Pharma LLC. Nasrat Hakim is the sole beneficial owner of Mikah Pharma LLC.